Spain's Grifols announced it will acquire the remaining share of Alkahest that it doesn't already own for $146 million. The deal will create opportunities for Grifols to develop novel therapies for diseases that are age-related.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.